ArticleJournal of applied phycology2013
The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.
Article in Journal of applied phycology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 75 citations in OpenAlex.
- Commercial importance of seaweeds: an overview.Bioresources and bioprocessing · 2025Review
- A cross-sectional study on the relationship between dietary fiber and endometriosis risk based on NHANES 1999-2006.Scientific reports · 2024Article
- Seaweeds as Nutraceutical Elements and Drugs for Diabetes Mellitus: Future Perspectives.Marine drugs · 2024Review
- Brown AlgaeMarine drugs · 2024Article
- Green seaweeds fatty acids and heterocyclic derivatives against cancer: Opinion on future nutraceutical application.Frontiers in oncology · 2023Article
- Effects of whole seaweed consumption on humans: current evidence from randomized-controlled intervention trials, knowledge gaps, and limitations.Frontiers in nutrition · 2023Review
- Nutrition in the prevention and treatment of endometriosis: A review.Frontiers in nutrition · 2023Review
- Fucoxanthin Holds Potential to Become a Drug Adjuvant in Breast Cancer Treatment: Evidence from 2D and 3D Cell Cultures.Molecules (Basel, Switzerland) · 2021Article
- Iodine, Seaweed, and the Thyroid.European thyroid journal · 2021Review
- Article
- Current Trends on Seaweeds: Looking at Chemical Composition, Phytopharmacology, and Cosmetic Applications.Molecules (Basel, Switzerland) · 2019Review
- Brown SeaweedMolecules (Basel, Switzerland) · 2019Article
- Degradation of Fucoxanthin to Elucidate the Relationship between the Fucoxanthin Molecular Structure and Its Antiproliferative Effect on Caco-2 Cells.Marine drugs · 2018Article
- Recent Advances in Marine Algae Polysaccharides: Isolation, Structure, and Activities.Marine drugs · 2017Review
- An Insight into Sargassum muticum Cytoprotective Mechanisms against Oxidative Stress on a Human Cell In Vitro Model.Marine drugs · 2017Article
- Melanoma and brown seaweed: an integrative hypothesis.Journal of applied phycology · 2017Article
- Supplementation of Seaweeds Extracts Suppresses Azoxymethane-induced Aberrant DNA Methylation in Colon and Liver of ICR Mice.Journal of cancer prevention · 2014Article
- Fucoxanthin: a marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms.Marine drugs · 2013Review
- Anticancer and cancer preventive properties of marine polysaccharides: some results and prospects.Marine drugs · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Daily consumption of seaweed has been proposed as a factor in explaining lower postmenopausal breast cancer (BC) incidence and mortality rates in Japan. This clinical trial assessed the impact of introducing seaweed- to non-seaweed-consuming American postmenopausal women. Fifteen healthy postmenopausal women were recruited for a 3-month single-blinded placebo controlled clinical trial; five had no history of BC (controls) and ten were BC survivors. Participants ingested ten capsules daily (5 g day
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.